Linnaeus Therapeutics LLC
Linnaeus Therapeutics LLC is a biotech company in Philadelphia, United States, founded in 2018. It has 3 recorded funding rounds.
Promoting resilience against cancer, cardiometabolic disease, and aging
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2G
- Website
- linnaeustx.com
- Rounds
- 3
Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.
About
Linnaeus Therapeutics is a clinical-stage biopharmaceutical company developing GPER-targeted medicines for cancer, cardiometabolic disease, and healthy aging. Their lead candidate, LNS8801, is a first-in-class oral GPER agonist with clinical evidence of antitumor activity and cardiometabolic benefits. The company has received multiple NCI SBIR awards totaling over $8M and is collaborating with Merck on combination trials with KEYTRUDA.
Summary
It lists 1–10 employees. Investors include Kairos Ventures and ARPA-H.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to see all 3 events
Funding, valuations, and company events, with amounts and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/linnaeus-therapeutics-llc"><img src="https://indexed.vc/api/badge/company/linnaeus-therapeutics-llc" alt="Linnaeus Therapeutics LLC on Indexed.vc" width="260" height="76" /></a>